ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,818,568 | -20.4% | 11,350,085 | 0.0% | 2.53% | -8.2% |
Q2 2023 | $95,227,213 | -15.5% | 11,350,085 | 0.0% | 2.76% | -17.2% |
Q1 2023 | $112,706,344 | +42.7% | 11,350,085 | 0.0% | 3.33% | +50.0% |
Q4 2022 | $78,996,592 | +30.3% | 11,350,085 | 0.0% | 2.22% | +26.1% |
Q3 2022 | $60,609,000 | +53.4% | 11,350,085 | +14.6% | 1.76% | +42.1% |
Q2 2022 | $39,516,000 | -10.2% | 9,903,879 | 0.0% | 1.24% | +40.4% |
Q1 2022 | $44,023,000 | -44.4% | 9,903,879 | -50.0% | 0.88% | +44.4% |
Q4 2021 | $79,232,000 | -8.9% | 19,807,758 | +100.0% | 0.61% | -51.6% |
Q3 2021 | $86,956,000 | -61.3% | 9,903,879 | -50.0% | 1.26% | -13.4% |
Q2 2021 | $224,422,000 | +117.0% | 19,807,758 | +127.6% | 1.46% | +11.5% |
Q1 2021 | $103,402,000 | +139.8% | 8,703,879 | +38.5% | 1.31% | +182.5% |
Q4 2020 | $43,118,000 | -7.4% | 6,285,458 | 0.0% | 0.46% | -31.9% |
Q3 2020 | $46,575,000 | +262.0% | 6,285,458 | +103.7% | 0.68% | +226.9% |
Q2 2020 | $12,866,000 | +68.8% | 3,085,458 | 0.0% | 0.21% | +5.1% |
Q1 2020 | $7,621,000 | -57.5% | 3,085,458 | 0.0% | 0.20% | -44.4% |
Q4 2019 | $17,926,000 | +10.2% | 3,085,458 | 0.0% | 0.36% | -18.7% |
Q3 2019 | $16,260,000 | -12.2% | 3,085,458 | 0.0% | 0.44% | +3.1% |
Q2 2019 | $18,512,000 | -33.6% | 3,085,458 | 0.0% | 0.42% | -45.9% |
Q1 2019 | $27,862,000 | +12.9% | 3,085,458 | 0.0% | 0.79% | -16.3% |
Q4 2018 | $24,684,000 | -42.0% | 3,085,458 | 0.0% | 0.94% | -17.6% |
Q3 2018 | $42,579,000 | +73.6% | 3,085,458 | 0.0% | 1.14% | +77.1% |
Q2 2018 | $24,529,000 | +6.0% | 3,085,458 | 0.0% | 0.64% | -0.8% |
Q1 2018 | $23,141,000 | +10.3% | 3,085,458 | 0.0% | 0.65% | -6.8% |
Q4 2017 | $20,981,000 | -52.8% | 3,085,458 | -50.0% | 0.70% | -18.0% |
Q3 2017 | $44,430,000 | +231.1% | 6,170,916 | +113.9% | 0.85% | +25.6% |
Q2 2017 | $13,417,000 | +4.0% | 2,885,458 | 0.0% | 0.68% | -8.2% |
Q1 2017 | $12,897,000 | +24.2% | 2,885,458 | +48.7% | 0.74% | -0.4% |
Q4 2016 | $10,381,000 | -31.6% | 1,940,458 | 0.0% | 0.74% | -24.6% |
Q3 2016 | $15,174,000 | +37.4% | 1,940,458 | 0.0% | 0.98% | +28.0% |
Q2 2016 | $11,041,000 | +112.4% | 1,940,458 | +56.4% | 0.76% | +67.8% |
Q1 2016 | $5,197,000 | -38.2% | 1,240,458 | 0.0% | 0.46% | -26.7% |
Q4 2015 | $8,410,000 | -24.6% | 1,240,458 | -35.2% | 0.62% | +39.5% |
Q3 2015 | $11,160,000 | +65.4% | 1,914,386 | +120.1% | 0.45% | +9.9% |
Q2 2015 | $6,749,000 | +85.7% | 869,800 | +143.6% | 0.41% | +44.0% |
Q1 2015 | $3,634,000 | – | 357,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |